Skip to main content

Medication Adherence

  • Chapter
  • First Online:
Improving Patient Treatment Adherence

Abstract

A key component in the management of health-care conditions is the use of prescribed medications. The effectiveness of medications and their long-term benefits depends on adherence to the prescriber’s instructions [1]. Adherence is defined as the extent to which people follow the instructions they are given for prescribed treatments [2]; it involves consumer choice and is intended to be non-judgmental, unlike compliance, which reinforces patient passivity and blame. On the other hand, concordance refers to an emerging consultative and consensual partnership between the consumer and their doctor [2]. Medication adherence behavior has been divided into two main concepts, namely adherence and persistence. Although conceptually similar, adherence refers to the intensity of drug use during the duration of therapy, whereas persistence refers to overall duration [3]. Medication non-adherence includes delaying prescription fills, failing to fill prescriptions, cutting dosages, and reducing the frequency of administration.

Drugs don’t work in patients who don’t take them.

US Surgeon General, C. Everett Koop MD

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sabate E. Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: World Health Organization; 2003.

    Google Scholar 

  2. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP. Interventions to enhance medication adherence. Cochrane Database Syst Rev. 2005;4:CD000011.

    PubMed  Google Scholar 

  3. Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47.

    Article  PubMed  Google Scholar 

  4. World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization; 2003.

    Google Scholar 

  5. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.

    Article  PubMed  CAS  Google Scholar 

  6. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455–461.

    Article  PubMed  Google Scholar 

  7. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279(18):1458–1462.

    Article  PubMed  CAS  Google Scholar 

  8. Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care. 2005;43(6):517–520.

    Article  PubMed  Google Scholar 

  9. Feldman R, Bacher M, Campbell N, Drover A, Chockalingam A. Adherence to pharmacologic management of hypertension. Can J Public Health. 1998;89(5):I16–I18.

    PubMed  CAS  Google Scholar 

  10. Flack J, Novikov, SV, Ferrario CM. Benefits of adherence to antihypertensive drug therapy. Eur Soc Cardiol. 1996;17(Suppl A):16–20.

    Google Scholar 

  11. Mallion JM, Baguet JP, Siche JP, Tremel F, de Gaudemaris R. Compliance, electronic monitoring and antihypertensive drugs. J Hypertens Suppl. 1998;16(1):S75–S79.

    PubMed  CAS  Google Scholar 

  12. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348(9024):383–386.

    Article  PubMed  CAS  Google Scholar 

  13. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36(9):1331–1336.

    Article  PubMed  Google Scholar 

  14. Rodgers PT, Ruffin DM. Medication nonadherence–Part I: the health and humanistic consequences. Manag Care Interface. 1998;11(8):58–60.

    PubMed  CAS  Google Scholar 

  15. Schiff GD, Fung S, Speroff T, McNutt RA. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med. 2003;114(8):625–630.

    Article  PubMed  Google Scholar 

  16. Senst BL, Achusim LE, Genest RP, Cosentino LA, Ford CC, Little JA, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm. 2001;58(12):1126–1132.

    PubMed  CAS  Google Scholar 

  17. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–1841.

    Article  PubMed  Google Scholar 

  18. McCarthy R. The price you pay for the drug not taken. Bus Health 1998;16:27–33.

    PubMed  CAS  Google Scholar 

  19. National Council on Patient Information and Education. Enhancing prescription medication adherence: a national action plan http://www.talkaboutrx.org/documents/enhancing_prescription_medicine_adherence.pdf. Accessed 6/2/2008.

  20. Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shevlin N. Medication compliance: a healthcare problem. Ann Pharmacother. 1993;27(9 Suppl):S1–S24.

    PubMed  CAS  Google Scholar 

  21. Levy G, Zamacona MK, Jusko WJ. Developing compliance instructions for drug labeling. Clin Pharmacol Ther. 2000;68(6):586–591.

    Article  PubMed  CAS  Google Scholar 

  22. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794–811.

    Article  PubMed  Google Scholar 

  23. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is this patient taking the treatment as prescribed? JAMA. 1993;269(21):2779–2781.

    Article  PubMed  CAS  Google Scholar 

  24. Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37(9):846–857.

    Article  PubMed  CAS  Google Scholar 

  25. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105–116.

    Article  PubMed  CAS  Google Scholar 

  26. Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA. Electronic monitoring and counseling to improve medication adherence. Behav Res Ther. 2004;42(4):409–422.

    Article  PubMed  Google Scholar 

  27. Morisky E, Green, LW, Levine, DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.

    Article  PubMed  CAS  Google Scholar 

  28. Thorpe C, Bryson CL, Maciejewski, ML, Bosworth, HB. Medication acquisition and self-reported adherence in veterans with hypertension. Med Care. 2009;47(4): 474–481.

    Article  PubMed  Google Scholar 

  29. Morgan AL, Masoudi FA, Havranek EP, Jones PG, Peterson PN, Krumholz HM, et al. Difficulty taking medications, depression, and health status in heart failure patients. J Card Fail. 2006;12(1):54–60.

    Article  PubMed  Google Scholar 

  30. Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother. 2009;43(3):413–422.

    Article  PubMed  Google Scholar 

  31. Dunbar-Jacob J, Dwyer K, Dunning EJ. Compliance with antihypertensive regimen: a review of the research in the 1980s. Ann Behav Med. 1991;13(1):31–39.

    Google Scholar 

  32. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288(22):2880–2883.

    Article  PubMed  Google Scholar 

  33. Shalansky SJ, Levy AR, Ignaszewski AP. Self-reported Morisky score for identifying nonadherence with cardiovascular medications (September). Ann Pharmacother. 2004;38(9):1363–1368.

    Google Scholar 

  34. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. The rational clinical examination. Is this patient taking the treatment as prescribed? JAMA. 1993;269(21):2779–2781.

    Article  PubMed  CAS  Google Scholar 

  35. Lowry KP, Dudley TK, Oddone EZ, Bosworth HB. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother. 2005;39(7–8):1198–1203.

    Article  PubMed  Google Scholar 

  36. Bosworth HB, George LK, Hays JC, Steffens DC. Psychosocial and clinical factors as predictors of the outcome of unipolar depression. Int J Geriatr Psychiatry. 2002;17(3):238–246.

    Article  PubMed  Google Scholar 

  37. Bosworth HB, Olsen MK, Oddone EZ. Improving blood pressure control by tailored feedback to patients and clinicians. Am Heart J. 2005;149(5):795–803.

    Article  PubMed  Google Scholar 

  38. Bosworth HB. Medication adherence. In: Bosworth HB. OE, Weinberger M, eds. Patient treatment adherence: Concepts, interventions, and measurement. Mahwah, NJ: Lawrence Erlbaum Associates; 2006.

    Google Scholar 

  39. Ickovics JR, Meisler AW. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol. 1997;50(4):385–391.

    Article  PubMed  CAS  Google Scholar 

  40. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2002;2:CD000011.

    PubMed  Google Scholar 

  41. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002;288(22):2868–2879.

    Article  PubMed  Google Scholar 

  42. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008;31(3):213–224.

    Article  PubMed  Google Scholar 

  43. Richter A, Anton SE, Koch P, Dennett SL. The impact of reducing dose frequency on health outcomes. Clin Ther. 2003;25(8):2307–2335; discussion 6.

    Article  PubMed  Google Scholar 

  44. Seedat YK. Fixed drug combination in hypertension and hyperlipidaemia in the developing world. Cardiovasc J Afr. 2008;19(3):124–126.

    PubMed  CAS  Google Scholar 

  45. Makaryus AN, Friedman EA. Patients’ understanding of their treatment plans and diagnosis at discharge. Mayo Clin Proc. 2005;80(8):991–994.

    Article  PubMed  Google Scholar 

  46. Coleman EA, Mahoney E, Parry C. Assessing the quality of preparation for posthospital care from the patient’s perspective: the care transitions measure. Med Care. 2005;43(3):246–255.

    Article  PubMed  Google Scholar 

  47. Wamala S, Merlo J, Bostrom G, Hogstedt C, Agren G. Socioeconomic disadvantage and primary non-adherence with medication in Sweden. Int J Qual Health Care. 2007;19(3):134–140.

    Article  PubMed  Google Scholar 

  48. McCray AT. Promoting health literacy. J Am Med Inform Assoc. 2005;12:152–163.

    Article  PubMed  Google Scholar 

  49. Institute of Medicine. Health literacy. A prescription to end confusion. Washington, DC: National Academies Press; 2004.

    Google Scholar 

  50. United States Department of Education. National assessment of adult literacy: A first look at the literacy of America’s adults in the 21st century. Washington, DC: National Center for Education Statistics; 2005.

    Google Scholar 

  51. Gazmararian JA, Baker DW, Williams MV, Parker RM, Scott TL, Green DC, et al. Health literacy among Medicare enrollees in a managed care organization. JAMA. 1999;281(6):545–551.

    Article  PubMed  CAS  Google Scholar 

  52. Williams M, Parker, RM., Baker, DW, et al. Inadequate functional health literacy among patients at two public hospitals. J Am Med Assoc. 1995;274(21):1677–1682.

    Article  CAS  Google Scholar 

  53. Wilson FL, Racine E, Tekieli V, Williams B. Literacy, readability and cultural barriers: critical factors to consider when educating older African Americans about anticoagulation therapy. J Clin Nurs. 2003;12(2):275–282.

    Article  PubMed  Google Scholar 

  54. Nelson W, Reyna VF, Fagerlin A, Lipkus I, Peters E. Clinical implications of numeracy: theory and practice. Ann Behav Med. 2008;35(3):261–274.

    Article  PubMed  Google Scholar 

  55. Gazmararian JA, Williams MV, Peel J, Baker DW. Health literacy and knowledge of chronic disease. Patient Educ Couns. 2003;51(3):267–275.

    Article  PubMed  Google Scholar 

  56. Parker RM, Gazmararian JA. Health literacy: essential for health communication. J Health Commun. 2003;8(Suppl 1):116–118.

    Article  PubMed  Google Scholar 

  57. Mehta S, Moore RD, Graham NM. Potential factors affecting adherence with HIV therapy. AIDS. 1997;11(14):1665–1670.

    Article  PubMed  CAS  Google Scholar 

  58. Isaac IM, Tamblyn RM. Compliance and cognitive function: a methodological approach to measuring unintentional errors in medication compliance in the elderly. Gerontologist. 1993;33:772–781.

    Article  PubMed  CAS  Google Scholar 

  59. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med. 2006;166(17):1855–1862.

    Article  PubMed  Google Scholar 

  60. Svarstad BL, Bultman DC, Mount JK. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness. J Am Pharm Assoc 2004;44(1):22–29.

    Article  Google Scholar 

  61. Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff (Millwood). 2007;26(3):731–740.

    Article  Google Scholar 

  62. Lee PP, Hoskins HD, Jr., Parke DW, 3rd. Access to care: eye care provider workforce considerations in 2020. Arch Ophthalmol. 2007;125(3):406–410.

    Article  PubMed  Google Scholar 

  63. Simmons D, Rush E, Crook N. Development and piloting of a community health worker-based intervention for the prevention of diabetes among New Zealand Maori in Te Wai o Rona: Diabetes Prevention Strategy. Public Health Nutr. 2008;11(12):1318–1325.

    Article  PubMed  CAS  Google Scholar 

  64. Simmons D, Voyle J, Rush E, Dear M. The New Zealand experience in peer support interventions among people with diabetes. Fam Pract. 2009:1–9.

    Google Scholar 

  65. Organization WH. Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization; 2003.

    Google Scholar 

  66. Paez KA, Zhao L, Hwang W. Rising out-of-pocket spending for chronic conditions: a ten-year trend. Health Aff (Millwood). 2009;28(1):15–25.

    Article  Google Scholar 

  67. Solomon MD, Goldman DP, Joyce GF, Escarce JJ. Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med. 2009;169(8):740–748; discussion 8–9.

    Article  PubMed  Google Scholar 

  68. Safran DG, Neuman P, Schoen C, Kitchman MS, Wilson IB, Cooper B, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood). 2005; Suppl Web Exclusives:W5-152-W5-66.

    Google Scholar 

  69. Balint S, O’Donnell R. Beyond compliance. Occup Health Saf (Waco, Tex.) 2007;76(6):104, 6–7.

    PubMed  Google Scholar 

  70. Misra A, Ganda OP. Migration and its impact on adiposity and type 2 diabetes. Nutrition (Burbank, Los Angeles County, California). 2007;23(9):696–708.

    Article  PubMed  Google Scholar 

  71. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008(2):CD000011.

    Google Scholar 

  72. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med. 2007;167(6):540–550.

    Article  PubMed  Google Scholar 

  73. Conn VS, Hafdahl AR, Cooper PS, Ruppar TM, Mehr DR, Russell CL. Interventions to improve medication adherence among older adults: meta-analysis of adherence outcomes among randomized controlled trials. Gerontologist. 2009;49(4):447–462.

    Article  PubMed  Google Scholar 

  74. Miller N, Hill, MN, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997;95:1085–1090.

    Article  PubMed  CAS  Google Scholar 

  75. Hill MN, Miller NH. Compliance enhancement. A call for multidisciplinary team approaches. Circulation. 1996;93(1):4–6.

    Article  PubMed  CAS  Google Scholar 

  76. Schlenk EA, Bernardo LM, Organist LA, Klem ML, Engberg S. Optimizing medication adherence in older patients: a systematic review. J Clin Outcomes Manag. 2008;15(12):595–606.

    PubMed  Google Scholar 

  77. Russell CL, Conn VS, Jantarakupt P. Older adult medication compliance: integrated review of randomized controlled trials. Am J Health Behav. 2006;30(6):636–650.

    Article  PubMed  Google Scholar 

  78. van Eijken M, Tsang S, Wensing M, de Smet PA, Grol RP. Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature. Drugs Aging. 2003;20(3):229–240.

    Article  PubMed  Google Scholar 

  79. Russel M. Behavioral counseling in medicine: Strategies for modifying at-risk behavior. New York, NY: Oxford; 1986.

    Google Scholar 

  80. Taylor CB, Miller, NH. The behavioral approach. In: Wenger NK, Weinstein HK, eds. Rehabilitation of the coronary patient. New York, NY: Churchill Livingstone; 1992:461–471.

    Google Scholar 

  81. Heyscue BE, Levin GM, Merrick JP. Compliance with depot antipsychotic medication by patients attending outpatient clinics. Psychiatr Serv. 1998;49(9):1232–1234.

    PubMed  CAS  Google Scholar 

  82. Patton K, Meyers J, Lewis BE. Enhancement of compliance among patients with hypertension. Am J Manag Care. 1997;3(11):1693–1698.

    PubMed  CAS  Google Scholar 

  83. Berkman LF. Assessing the physical health effects of social networks and social support. Ann Rev Public Health. 1984;5:413–432.

    Article  CAS  Google Scholar 

  84. Cohen S. Social relationships and health. Am Psychol. 2004;59(8):676–684.

    Article  PubMed  Google Scholar 

  85. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207–218.

    Article  PubMed  Google Scholar 

  86. McCann BS, Retzlaff BM, Dowdy AA, Walden CE, Knopp RH. Promoting adherence to low-fat, low-cholesterol diets: review and recommendations. J Am Diet Assoc. 1990;90(10):1408–1414.

    PubMed  CAS  Google Scholar 

  87. Bovbjerg VE, McCann BS, Brief DJ, Follette WC, Retzlaff BM, Dowdy AA, et al. Spouse support and long-term adherence to lipid-lowering diets. Am J Epidemiol. 1995;141(5):451–460.

    PubMed  CAS  Google Scholar 

  88. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19(2):124–133.

    Article  PubMed  CAS  Google Scholar 

  89. Sherbourne CD, Hays RD, Ordway L, DiMatteo MR, Kravitz RL. Antecedents of adherence to medical recommendations: results from the medical outcomes study. J Behav Med. 1992;15(5):447–468.

    Article  PubMed  CAS  Google Scholar 

  90. Ogedegbe G, Harrison M, Robbins L, Mancuso CA, Allegrante JP. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. Ethn Dis. 2004;14(1):3–12.

    PubMed  Google Scholar 

  91. Molassiotis A, Nahas-Lopez V, Chung WY, Lam SW, Li CK, Lau TF. Factors associated with adherence to antiretroviral medication in HIV-infected patients. Intern J STD AIDS. 2002;13(5):301–310.

    Article  Google Scholar 

  92. Voils C, Steinhauser K, McCant F, Oddone E, Bosworth HB. Understanding adherence to blood pressure-lowering regimens: A qualitative study of facilitators and barriers. Baltimore, MD: Health Services Research and Development National Meeting; 2005.

    Google Scholar 

  93. Kopjar B, Sales AE, Pineros SL, Sun H, Li YF, Hedeen AN. Adherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male population. Am J Cardiol. 2003;92(9):1106–1108.

    Article  PubMed  Google Scholar 

  94. Pratt J, Jones, JJ. Noncompliance with therapy: an ongoing problem in treating hypertension. Prim Cardiol. 1995;21:34–38.

    Google Scholar 

  95. Urquhart J. Correlates of variable patient compliance in drug trials: relevance in the new health care environment. Adv Drug Res. 1995;26:237–257.

    Article  Google Scholar 

  96. Sivarajan ES, Newton KM, Almes MJ, Kempf TM, Mansfield LW, Bruce RA. Limited effects of outpatient teaching and counseling after myocardial infarction: a controlled study. Heart Lung. 1983;12(1):65–73.

    PubMed  CAS  Google Scholar 

  97. Haynes R, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS, Johnson AL. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976;1:1265–1268.

    Article  PubMed  CAS  Google Scholar 

  98. Bailey WC, Richards JM, Jr., Brooks CM, Soong SJ, Windsor RA, Manzella BA. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med. 1990;150(8):1664–1668.

    Article  PubMed  CAS  Google Scholar 

  99. Levine RJ. Monitoring for adherence: ethical considerations. Am J Respir Crit Care Med. 1994;149(2 Pt 1):287–288.

    PubMed  CAS  Google Scholar 

  100. Ciechanowski PS, Katon WJ, Russo JE, Walker EA. The patient-provider relationship: attachment theory and adherence to treatment in diabetes. Am J Psychiatry. 2001;158(1):29–35.

    Article  PubMed  CAS  Google Scholar 

  101. Alexander SC, Sleath B, Golin CE, Kalinowski CT. Patient-provider communication. In: Bosworth HB, Oddone EZ, Weinberger M, eds. Patient treatment adherence: Concepts, interventions, and measurement. Mahwah, NJ: Lawrence Erlbaum Associates; 2006:329–372.

    Google Scholar 

  102. Bender BG. Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol. 2002;109(6 Suppl):S554–S559.

    Article  PubMed  Google Scholar 

  103. Horne R. Patients’ beliefs about treatment: the hidden determinant of treatment outcome? J Psychosom Res. 1999;47(6):491–495.

    Article  PubMed  CAS  Google Scholar 

  104. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med. 2000;342(3):145–153.

    Article  PubMed  CAS  Google Scholar 

  105. Haynes RB, Montague P, Oliver T, McKibbon KA, Brouwers MC, Kanani R. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2000;2:CD000011.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hayden B. Bosworth PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Bosworth, H.B. (2010). Medication Adherence. In: Bosworth, H. (eds) Improving Patient Treatment Adherence. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5866-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-5866-2_4

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-5865-5

  • Online ISBN: 978-1-4419-5866-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics